Stay updated with breaking news from Ryan Noach. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A large-scale analysis in South Africa says that two-dose Pfizer/BioNTech vaccination provides just 33% protection against infection by the omicron coronavirus variant but 70% protection against hospitalization. Tuesday's first large-scale
A study in South Africa, where the Omicron variant was first found, appears to show the new strain of COVID-19 is more transmissible, but less deadly.
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
The new coronavirus variant, called omicron, was first identified in South Africa only about a month ago and is already spreading quickly in Europe and
Data from 78,000 South Africans with COVID show the Pfizer vaccine is far less effective in preventing infection by the omicron variant. But there is still significant protection from severe illness.